🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open, non-randomized Phase Ib-II trial of dose-escalation and cohorts ex...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2023-02-28
Trial ID
NCT05701306
This is a two Part study in patients with relapsed/refractory acute myeloid...
Status
Unknown
Location
Banner MD Anderson Cancer Center
Start Date
2020-12-04
Trial ID
NCT04358393
Treatments Being Tested
This study aims to assess the safety, tolerability, pharmacokinetics, and p...
Status
Active Not Recruiting
Location
University of Arizona Cancer Center
Start Date
2018-08-29
Trial ID
NCT03611868
Treatments Being Tested
Background: Mesothelioma is a rare cancer typically caused by exposure to ...
Status
Withdrawn
Location
National Institutes of Health Clinical Center
Start Date
2026-03-16
Trial ID
NCT06654050
Treatments Being Tested
Part 1 is a phase Ib standard "3 + 3" design, will be employed to determine...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2021-05-26
Trial ID
NCT04785196
Treatments Being Tested
This is a phase I/II trial to evaluate the efficacy of APG-115 +/- Carbopla...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2019-10-28
Trial ID
NCT03781986
Treatments Being Tested
Acute myeloid leukemia is a malignant disorder characterized by the rapid, ...
Status
Recruiting
Location
The First Hospital of Peking University
Start Date
2020-07-06
Trial ID
NCT04275518
Treatments Being Tested
The goal of this study is to evaluate the pharmacokinetics (PK), safety, an...
Status
Recruiting
Location
MD Anderson
Start Date
2021-07-12
Trial ID
NCT04496349
This is a phase 0/1/2, multi-site study to evaluate the MEK inhibitor Selum...
Status
Recruiting
Location
Children's National Hospital
Start Date
2026-06-01
Trial ID
NCT06735820
Treatments Being Tested
APG-115 is a novel, orally active small-molecule mouse double minute 2 homo...
Status
Completed
Location
START Midwest
Start Date
2016-10
Trial ID
NCT02935907
Treatments Being Tested